AGP Executive Report
Last update: 5 hours agoNHS Breakthrough: UCLH-led CAR T-cell therapy trial reports 5 of 6 people with severe lupus went into remission, with kidney function stabilising or improving after treatment. Vaccination Push: Teenagers in school year 13 and new university starters will get two doses of MenB vaccine from late July after recent outbreaks in Kent, Dorset and Berkshire. Weight-loss Drugs: MHRA has approved Novo Nordisk’s oral semaglutide weight-loss pill, giving adults with obesity (or BMI 27-30 with conditions) a needle-free option. NHS Data & Privacy Row: Anti-Palantir protesters gathered at an NHS conference in Manchester, arguing a deal over health-data analytics raises security and privacy concerns. Public Health Alert: UKHSA says pandemic-capable respiratory infections remain the biggest threat, alongside antimicrobial resistance, in its first Health Security Risk Assessment. Measles Warning: UKHSA reports two more child deaths and 106 new cases in two weeks, urging parents to keep MMR up to date. Care Access Pressure: NHS corridor care figures show nearly 3,000 patients a day being treated outside wards, highlighting ongoing flow problems. Health Controversy: A Brighton GP investigation alleges unsafe prescribing of sex hormones to children as young as 12, with concerns over assessments and consent.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.